Understanding the needs of women considering risk-reducing salpingo-oophorectomy

Cancer Nursing

Volumn 36, Issue 3, 2013, Pages

  Cherry, Carol ^a   Ropka, Mary ^b   Lyle, Jennifer ^c   Napolitano, Laura ^d   Daly, Mary B ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c National Comprehensive Cancer Network   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

BRCA1 2 positive women; Decision making; Ovarian cancer risk; Risk perception; Risk reducing salpingooophorectomy; Uncertainty

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CANCER PREVENTION; CANCER RISK; CLINICAL ARTICLE; CONTENT ANALYSIS; DECISION SUPPORT SYSTEM; FEAR; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; INTERVIEW; MENOPAUSE; OVARIECTOMY; OVARY CANCER; PATIENT DECISION MAKING; PERCEPTION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RISK ASSESSMENT; RISK REDUCTION; SALPINGOOOPHORECTOMY;

ADULT; BIOLOGICAL MARKERS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; NEEDS ASSESSMENT; OVARIAN NEOPLASMS; OVARIECTOMY; RISK FACTORS; RISK REDUCTION BEHAVIOR; SALPINGECTOMY; SAMPLING STUDIES;

EID: 84877042223     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e3182642cb5     Document Type: Article

References (27)

1. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72(5):1117-1130
2. Kauff ND, Domchek SM, Friebel TM, et al. Risk-reducing salpingooophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol. 2008;26(8):1331-1337
3. Chen S, Iversen ES, Friebel T, et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006; 24(6):863-871
4. Hermsen BB, Olivier RI, Verheijen RH, et al. No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. Br J Cancer. 2007;96(9):1335-1342
5. Daly MB, Axilbund JE, Buys S, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2010;8(5):562-594
6. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009;101(2):80-87
7. Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967-975
8. Tiller K, Meiser B, Butow P, et al. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study. Gynecol Oncol. 2002;86(2):212-219
9. Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol. 2005; 23(28):6890-6898
10. Politi MC, Han PK, Col NF. Communicating the uncertainty of harms and benefits of medical interventions. Med Decis Making. 2007;27(5): 681-695
11. Howard AF, Bottorff JL, Balneaves LG, Kim-Sing C. Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy. BMC Womens Health. 2010;10:24
12. Thompson D, Easton D. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet. 2001;68(2):410-419
13. Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007;25(25):3985-3990
14. Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB. A prospective study of quality of life among women undergoing risk-reducing salpingooophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol. 2009;112(3):594-600
15. Evans DG, Lalloo F, Ashcroft L, et al. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomarkers Prev. 2009;18(8): 2318-2324
16. Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2008;122(9):2017-2022
17. Brain K, Gravell C, France E, Fiander A, Gray J. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making. Gynecol Oncol. 2004;92(3):905-913
18. Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334-340
19. Lipworth WL, Davey HM, Carter SM, Hooker C, Hu W. Beliefs and beyond: what can we learn from qualitative studies of lay people's understandings of cancer risk? Health Expect. 2010;13(2):113-124
20. Pyke S, Agnew N. The Science Game, An Introduction to Research in the Social Sciences. New Jersey: Oxford University Press; 1991
21. Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med. 2006;62(6):1360-1368
22. Madalinska JB, van Beurden M, Bleiker EM, et al. Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers. J Clin Oncol. 2007;25(3): 301-307
23. Howard AF, Balneaves LG, Bottorff JL. Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review. J Genet Couns. 2009;18(6):578-597
24. Ray JA, Loescher LJ, Brewer M. Risk-reduction surgery decisions in high-risk women seen for genetic counseling. J Genet Couns. 2005;14(6): 473-484
25. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988;15(2):175-183
26. Bandura A. Self-efficacy: The Exercise of Control. New York: WH Freeman; 1997
27. Euhus DM, Smith KC, Robinson L, et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst. 2002;94(11):844-851